Pharmaceutical

Atantares raises $13.9m in pre-Series A funding to develop molecular chips

Atantares plans to use the $13.9m funding for research and development, service operation, and capacity expansion.

Aug 2, 2023 - 20:00
Atantares raises $13.9m in pre-Series A funding to develop molecular chips
Atantares plans to use the $13.9m funding for research and development, service operation, and capacity expansion.
Read the original article

Tags:

Previous Article

CS Pharmaceuticals snaps up AxeroVision to shore up ophthalmology portfolio

Next Article

FDA warns of reduced efficacy for oral birth control pill Tydemy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Immunocore and BMS partner to investigate first-line treatment for melanoma

Immunocore and BMS partner to investigate first-line tr...

Feb 22, 2024

STAT+: AI health care companies say they’ll keep humans in the loop. But what does that actually mean?

STAT+: AI health care companies say they’ll keep humans...

Mar 13, 2024

ImmunityBio partners with Serum Institute for BCG vaccines

ImmunityBio partners with Serum Institute for BCG vaccines

May 5, 2024